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Results. We found no signiﬁcant differences in the value of the corrections made by each expert on the isocenter (p>0.05 ANOVA
test) for various diseases.
Conclusions. The value of the coordinate shifts resulting from the relocation of the isocenter by performing portal imaging does
not depend on the radiation oncologist according to our analysis. It may be concluded that the method is “objective”, although
nothing can be stated about the suitability of the corrections in terms of size and direction regarding algorithmic methods of
image processing.
http://dx.doi.org/10.1016/j.rpor.2013.03.610
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Introduction. The pelvic irradiation is needed in several pathologies and is, in general, planned with high energy (15–18MV) photon
beams. However, since 6MV photon beams were accepted as an effective energy choice for most IMRT cases, more and more
radiotherapy services are acquiring linear accelerators without these high energy photon beams. Besides the issues concerning
increased leakage and secondaryneutrondose for thepatientswhenusinghigh-energyphotons, this choice canhave a signiﬁcant
economical impact in departments or countries with limited resources.
Objectives. The purpose of this work was to evaluate the use of 6MV beams to treat pelvic volumes, a situation in which
traditionally higher energies (15 or 18MV) are used.
Materials and methods. We selected 10 patients with rectum carcinoma. PTV and OAR volumes were delineated and alternative
plans (6MV vs. 18MV) were produced for two techniques: complex 3DCRT (multiple beams with segments) and IMRT (50Gy/25F).
The plans were evaluated and compared in terms of PTV coverage, dose to OAR and mean dose to the whole body.
Results. No signiﬁcant differences were found between 6MV and 18MV plans in terms of PTV coverage. Concerning the OAR,
we found a consistent increment in the mean dose to the femoral heads (average of 1.5Gy/25F) and whole body (average of
1.2Gy/25F) when using 6MV.
Conclusions. If complex 3DCRT techniques are used in pelvic irradiation, like in rectum cases, the use of 6MV beams is possible
and competitive in quality when compared to high-energy beams. Target and OAR volumes should be delineated for correct plan
evaluation. The option of completely waive high energy beams can only be taken if the department has the human and technical
resources to treat all these patients with complex 3D techniques.
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Stereotactic body radiotherapy (SBRT) treatment provides local disease control and pain relief with minimal side effects in the
treatment of spine metastases. The PTV surrounds the cord (very close to it), as a cylindrical shell wrapping around it. Spine SBRT
maintains the cord dose within tolerance as well as covers PTV suitably. The treatment time per fraction in SBRT can be improved
signiﬁcantly using volumetric modulated arc therapy (VMAT). This work shows our ﬁrst experience in the treatment of spine
metastases combining VMAT and SBRT techniques. The case reported consists on a spine lesion located in L4. PTV is expanded
from CTV with a 3mm margin. The prescription for SBRT treatment is 24Gy, delivered in 3 alternate-day fractions of 8Gy. 90%
of PTV should be covered with 100% of the prescription dose. Dose constraints for the cord are Dmax<14Gy and V10<10%.
Treatment is delivered with an Elekta Synergy linear accelerator, using VMAT technique. The plan consists in 2 full arcs resulting
in 432 control points. Plan quality is evaluated using DVH parameters: D99%, D95%, D90%, Dmean, D10%, D5% and D1%. Daily
cone-beamCTcorrections areperformedas image-guided radiation therapy technique tominimize geometric uncertainties. Valid
VMAT plan is generated by the TPS. Dose distribution wraps the cord, preserving it and covering the PTV with D90%=24.4Gy.
DVH parameters are D99%=16.6Gy, D95%=21.6Gy, Dmean=26.4Gy, D10%=27.9Gy, D5%=28.1Gy and D1%=28.4Gy. Maximum
dose in cord is 13.4Gy and V10=4.5Gy. This work presents the ﬁrst spine metastases case treated in our institution combining
SBRT and VMAT treatment techniques. Dosimetric parameters are consistent with those in literature, and cord dose preserve
the imposed constraints.
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